About Treace Medical Concepts
Treace Medical Concepts (NASDAQ:TMCI) is dedicated to innovating the field of orthopedics, focusing primarily on foot and ankle surgery solutions. The company is well-known for its pioneering Lapiplasty® 3D Bunion Correction™ system, which represents a significant advancement in treating bunion deformities by realigning and securing the foundational bone. Treace Medical Concepts aims to enhance surgical outcomes while reducing recovery times for patients. Alongside the development and marketing of cutting-edge medical devices, the company is deeply invested in clinical research to support the efficacy and safety of its products. Achieving operational excellence and expanding its product portfolio to address a wider range of orthopedic issues remain central to its objectives, with a strong commitment to improving patient quality of life through surgical innovation.
Snapshot
Operations
Products and/or services of Treace Medical Concepts
- Lapiplasty® 3D Bunion Correction® System: This is a patented surgical system designed to address bunion deformities at the root cause. It involves a combination of instruments, implants, and surgical techniques that aim to correct the bunion deformity in all three planes (frontal, transverse, and sagittal).
Treace Medical Concepts executive team
- Mr. John T. TreaceFounder, Chairman & CEO
- Mr. Mark L. Hair CPAChief Financial Officer
- Mr. Scot M. Elder J.D.Chief Legal & Compliance Officer and Corporate Secretary
- Dr. Sean F. Scanlan Ph.D.Chief Innovation Officer
- Mr. Gaetano M. GuglielminoChief Commercial Officer
- Mr. Terry W. LubbenChief Operations & Supply Chain Officer
- Mr. Taylor EricksonChief Information & Cybersecurity Officer
- Mr. Brad BarrSenior Vice President of Sales
- Mr. Daniel E. OwensChief Human Resources Officer
- Ms. Shana ZinkSenior Vice President of Clinical Affairs & Reimbursement